Learning Objectives:
- apply evidence-based surgical intervention for various stages and sites of head and neck cancer;
- the role of adjuvant or definitive radiation therapy in the treatment of the above based on literature;
- Be able to assess the role of chemotherapy use in the management of head and neck cancer in the neoadjuvant and concurrent radiotherapy settings.
Session date:
02/10/2022 - 7:00am to 9:00am CST
Location:
DCAM 1333
United States
See map: Google Maps
Add to calendar:
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Participation
Speaker Name:
Daniel Haraf, MD